| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
ATP binding cassette subfamily A member 1 | 0.467 | 0.846 | 1.5E-13 |
|
disease | 0.030 | None | 1.000 | 3 | 1 | 2016 | 2017 | ||||||||
|
ATP binding cassette subfamily A member 7 | 0.644 | 0.577 | 2.1E-55 |
|
disease | 0.020 | None | 1.000 | 2 | 1 | 2015 | 2018 | ||||||||
|
ABI family member 3 | 0.716 | 0.231 | 5.0E-05 |
|
disease | 0.010 | None | 1.000 | 1 | 1 | 2019 | 2019 | ||||||||
|
angiotensin I converting enzyme | 0.328 | 0.923 | 1.0E-37 |
|
disease | 0.100 | None | 1.000 | 11 | 0 | 2010 | 2019 | ||||||||
|
acetylcholinesterase (Cartwright blood group) | 0.445 | 0.885 | 1.00 |
|
disease | 0.040 | None | 1.000 | 4 | 0 | 2017 | 2019 | ||||||||
|
acyl-CoA thioesterase 7 | 0.531 | 0.769 | 0.76 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2009 | 2018 | ||||||||
|
actin beta like 2 | 0.539 | 0.769 | 5.8E-16 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2009 | 2018 | ||||||||
|
actin gamma 1 | 0.477 | 0.846 | 4.8E-03 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2009 | 2018 | ||||||||
|
actin gamma 2, smooth muscle | 0.505 | 0.808 | 7.1E-02 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2009 | 2018 | ||||||||
|
activin A receptor like type 1 | 0.493 | 0.769 | 9.7E-04 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 | ||||||||
|
aminoacylase 1 | 0.653 | 0.577 | 6.9E-09 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 | ||||||||
|
Alzheimer disease-10 | 0.743 | 0.269 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2018 | 2019 | |||||||||
|
Alzheimer disease-11 | 0.722 | 0.462 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2018 | 2019 | |||||||||
|
Alzheimer disease 12 | 0.711 | 0.538 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2018 | 2018 | |||||||||
|
Alzheimer disease 7 | 0.861 | 0.192 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2017 | 2017 | |||||||||
|
Alzheimer disease 8 | 1.000 | 0.038 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 | |||||||||
|
ADAM metallopeptidase domain 10 | 0.489 | 0.846 | 1.00 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2015 | 2019 | ||||||||
|
ADAM metallopeptidase with thrombospondin type 1 motif 2 | 0.579 | 0.808 | 0.97 |
|
disease | 0.040 | None | 1.000 | 4 | 0 | 2018 | 2019 | ||||||||
|
adiponectin, C1Q and collagen domain containing | 0.376 | 0.885 | 4.6E-09 |
|
disease | 0.060 | None | 0.833 | 6 | 0 | 2013 | 2019 | ||||||||
|
adrenomedullin | 0.436 | 0.808 | 4.1E-02 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2016 | 2016 | ||||||||
|
activity dependent neuroprotector homeobox | 0.561 | 0.808 | 1.00 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2017 | 2017 | ||||||||
|
adenosine A2a receptor | 0.526 | 0.769 | 0.60 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2010 | 2017 | ||||||||
|
adrenoceptor alpha 2B | 0.465 | 0.846 | 4.5E-06 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2013 | 2013 | ||||||||
|
advanced glycosylation end-product specific receptor | 0.420 | 0.885 | 6.4E-16 |
|
disease | 0.020 | None | 1.000 | 2 | 1 | 2016 | 2019 | ||||||||
|
alkylglycerone phosphate synthase | 0.670 | 0.538 | 1.00 |
|
disease | 0.100 | None | 1.000 | 14 | 0 | 2013 | 2019 |